Clinical Trials and Research
- 06.0427 - A Phase III, open label, randomized, comparative study of Ticilimumab and either Dacarbazine or Temozolomide in patients with advanced melanoma learn more
- 04.0648 - Biochemotherapy plus Digoxin in Patients with Metastatic Melanoma learn more
- 06.0076 - ONTAK with Metastatic melanoma learn more
- 07.0155 - A Phase I/II Dose Escalating Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of TKI258 in Patients with Locally Advanced or Metastatic Melanoma learn more
- 07.0157 - A Randomized, Double-blind, Phase 3 Trial of STA-4783 in Combination with Paclitaxel versus Paclitaxel Alone for Treatment of Chemotherapy-Naïve Subjects with Stage IV Metastatic Melanoma (SYMMETRY) learn more
|